罕见病知识库 RareSeen

系统性肥大细胞增多症

Systemic mastocytosis

ORPHA:2467疾病组中国目录 第2批 · 75

定义 英文原文(暂无中文)

A heterogeneous group of rare, acquired and chronic hematological malignancies related to an abnormal accumulation/proliferation of neoplastic mast cells (MCs) in one or several organs, mainly the bone marrow (BM), associated frequently with skin involvement.

基本事实

遗传方式
不适用
发病年龄
各年龄段
患病率
1-9 / 1 000 000(Italy)

相关基因 6来自下位疾病

Orphanet 未在本条目上直接标注致病基因。下表由本组所属的下位疾病汇总而来,「来源条目」列给出基因实际标注在哪一个 ORPHA 条目上。

基因名称来源条目
ASXL1ASXL transcriptional regulator 1ORPHA:98849
CBLCbl proto-oncogeneORPHA:98850
KITKIT proto-oncogene, receptor tyrosine kinaseORPHA:98849
RUNX1RUNX family transcription factor 1ORPHA:98850
SRSF2serine and arginine rich splicing factor 2ORPHA:98849
TET2tet methylcytosine dioxygenase 2ORPHA:98849

近两年的全球研究 18,820L2

2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。

  • 2026-11
    Evaluation of the Cornea of Dogs With Dry Eye Disease Using Spectral Domain Optical Coherence Tomography
    Veterinary ophthalmology · DOI · Europe PMC
  • 2026-10综述开放获取
    Chronic Spontaneous Urticaria and Psychiatric Symptoms: The Blood-Brain Barrier Hypothesis
    Experimental dermatology · DOI · Europe PMC
  • 2026-10开放获取
    Altered Inter-Network Functional Integration Underlies Speech Impairment in Parkinson's Disease: A Resting-State fMRI Analysis
    Brain and behavior · DOI · Europe PMC
  • 2026-10荟萃分析系统综述综述开放获取
    Comparison Between Skeletally-Anchored and Conventional Maxillary Protraction in Growing Class ΙΙΙ Patients: A Systematic Review and Meta-Analysis
    Clinical and experimental dental research · DOI · Europe PMC
  • 2026-10开放获取
    Exploring Cervical Cancer-Associated Vaginal and Cervical Microbiota via 16S rRNA Sequencing
    MicrobiologyOpen · DOI · Europe PMC
  • 2026-10开放获取
    Malassezia May Contribute to Basal Cell Carcinoma Development via Inflammatory and Oxidative Stress Pathways
    MicrobiologyOpen · DOI · Europe PMC
  • 2026-10开放获取
    Surgical Reconstructive Therapy of Peri-Implantitis via Submerged Versus Non-Submerged Healing: A 2-Year Retrospective Study
    Clinical implant dentistry and related research · DOI · Europe PMC
  • 2026-10开放获取
    Machine Learning Prediction of Anterior Open-Bite Development After Stabilization Splint Treatment in Temporomandibular Disorder
    Clinical and experimental dental research · DOI · Europe PMC
  • 2026-09病例报告开放获取
    More Than Just a Gut Feeling: Unmasking Systemic Mastocytosis Behind Chronic Gastrointestinal Symptoms in a 2-Patient Case Series
    ACG case reports journal · DOI · Europe PMC
  • 2026-09开放获取
    Nano spray-dried powders for efficient pulmonary delivery of proteins: an emphasis on comparisons of derived metrics determined by chapters <601> and <1604>
    Drug delivery · DOI · Europe PMC
  • 2026-09开放获取
    Integrated metagenomic and metabolomic analysis identifies severity-specific inflammatory and metabolic signatures in post-stroke depression
    Gut microbes · DOI · Europe PMC
  • 2026-09综述开放获取
    Diagnostic accuracy of AI-augmented renal ultrasound for degenerative kidney disorders: a systematic review and meta-analysis
    Future science OA · DOI · Europe PMC
  • 2026-09开放获取
    Ultrasound-guided botulinum toxin injection in patients with chronic plantar fasciitis: comparison of plantar fascia origin injection and the babcock method-a randomized controlled trial
    Future science OA · DOI · Europe PMC
  • 2026-09病例报告开放获取
    Digital 3D-Printed Surgical Guide for Removal of a Separated Instrument at the Maxillary Sinus Floor and Apical Microsurgery
    Journal of medical cases · DOI · Europe PMC
  • 2026-09开放获取
    Laparoscopically guided biopsy of non-macroscopically altered cecocolic lymph nodes in dog cadavers using laparoscopic forceps or core needles
    Veterinary and animal science · DOI · Europe PMC
  • 2026-09开放获取
    Evaluation of LLMs for Automated Dental-to-Medical Consult Letter Generation: Comparative Study
    International dental journal · DOI · Europe PMC
  • 2026-09开放获取
    Construction of a new predictive model in head and neck squamous cell carcinoma based on the investigation of extracellular matrix-associated genes
    Oncology letters · DOI · Europe PMC
  • 2026-09开放获取
    Periodontitis Exacerbates Insulin Resistance via Gut Barrier Dysfunction and TLR4/NF-κB Activation
    International dental journal · DOI · Europe PMC
  • 2026-09开放获取
    Haemodynamic effects of selective venoconstriction with centhaquine in spontaneously breathing patients with mixed hypovolaemic-vasodilatory shock
    Experimental physiology · 被引 1 · DOI · Europe PMC
  • 2026-08开放获取
    Bioactive glasses-mediated ion therapy ameliorates hepatic osteodystrophy by reprogramming the liver-bone axis
    Bioactive materials · DOI · Europe PMC

境外已获批用于本病的药物 2L2

欧盟 1 项、美国 1 项。同一药物在两地各批一次的,会分别列出。

「境外已获批」不等于「在中国能用」。中间隔着进口注册、临床急需境外新药通道、海南博鳌乐城国际医疗旅游先行区等几条路径,各有各的条件与费用。这一节能确定地告诉你的只有一件事:这个病在世界范围内已经有获得批准的药物,它叫什么名字。拿这个名字去问主治医生,是下一步最省力的做法。

药名一律保留英文原文,不作翻译——中国的药品通用名与英文名的音译经常不一致,译错会让人去找一个不存在的药。

数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。

在中国开展的临床试验 3L2

按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。

登记为可入组 1

  • 招募中NCT07562542
    Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
    观察性 · 2025/05/19The First Affiliated Hospital of Soochow University
    中国研究中心 1 个:Suzhou
其他状态的试验(2 项)
  • 状态未知NCT05504408
    Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid Leukemia
    观察性 · 2022/09/01The First Affiliated Hospital of Soochow University
    中国研究中心 1 个:Suzhou
  • 状态未知NCT06013683
    A Registry for Patients With Systemic Mastocytosis in China
    观察性 · 2023/09/01The First Affiliated Hospital of Soochow University
    中国研究中心 1 个:Suzhou

中国境外的在招试验 14L2

这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。

美国10意大利4德国3比利时3荷兰3挪威3英国3加拿大2澳大利亚2奥地利2法国2波兰2西班牙2瑞士2另有 9 个国家/地区

CT.gov 报告命中 14 项,此处取回并展示最近的 13 项。

  • 尚未开始招募NCT07819396
    Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
    II 期 · 干预性 · 2027/01/01Fred Hutchinson Cancer Center
    美国
  • 尚未开始招募NCT07757893
    Precision Medicine for Indolent Systemic Mastocytosis (PRISM)
    观察性 · 2026/09/09Mayo Clinic
    美国
  • 招募中NCT07264959
    An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
    观察性 · 2026/04/15Blueprint Medicines Corporation
    美国
  • 招募中NCT07255638
    A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
    观察性 · 2025/12/09Blueprint Medicines Corporation
    德国
  • 招募中NCT06748001
    Avapritinib Rollover Study
    IV 期 · 干预性 · 2024/11/28Blueprint Medicines Corporation
    比利时、加拿大、意大利、荷兰、挪威、英国
  • 招募中NCT06327685
    Avapritinib With Decitabine in Patients With SM-AHN
    I 期 · 干预性 · 2024/03/13H. Lee Moffitt Cancer Center and Research Institute
    美国
  • 招募中NCT07142473
    Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
    观察性 · 2024/01/26Fondazione IRCCS Policlinico San Matteo di Pavia
    意大利
  • 招募中NCT06210698
    Angioedema Biomarker Research Study
    观察性 · 2024/01/15Foundation For Rare Disease Research
    美国
  • 招募中NCT04910685
    (HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
    II 期、III 期 · 干预性 · 2021/11/30Blueprint Medicines Corporation
    阿根廷、澳大利亚、奥地利、比利时、巴西、哥伦比亚、捷克、法国 等 22 国
  • 招募中NCT04996875
    (Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
    II 期 · 干预性 · 2021/11/09Cogent Biosciences, Inc.
    澳大利亚、奥地利、比利时、加拿大、法国、德国、意大利、荷兰 等 14 国
  • 招募中NCT01137825
    Registry of Older Patients With Cancer
    观察性 · 2009/09UNC Lineberger Comprehensive Cancer Center
    美国
  • 招募中NCT01137643
    Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
    观察性 · 2009/07UNC Lineberger Comprehensive Cancer Center
    美国
  • 可获取(拓展性用药)NCT06915766
    Expanded Access to Bezuclastinib for Patients With NonAdvanced Systemic Mastocytosis or Advanced Systemic Mastocytosis
    拓展性用药Cogent Biosciences, Inc.
    美国

外部标识与链接

发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号

本页数据来源

  • 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
  • 中文病名:Orphanet 中文包,冻结于 2020-06-01
  • 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)